Literature DB >> 23293328

Body size phenotypes and low muscle mass: the Korean sarcopenic obesity study (KSOS).

Tae Nyun Kim1, Man Sik Park, Sae Jeong Yang, Hye Jin Yoo, Hyun Joo Kang, Wook Song, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Dong Seop Choi, Kyung Mook Choi.   

Abstract

CONTEXT: Unique subsets of body size phenotypes seem to be more prone or more resistant to the development of obesity-associated metabolic disorders, although the underlying mechanism is not yet clearly understood.
OBJECTIVES: We investigated the prevalence and risk of low muscle mass in subjects who are classified as either metabolically healthy normal weight (MHNW), metabolically abnormal but normal weight (MANW), metabolically healthy obese (MHO), or metabolically abnormal obese (MAO). Subjects were classified based on body mass index and presence of metabolic syndrome.
METHODS: Thigh muscle cross-sectional area was evaluated using computed tomography as an index of muscle mass in 492 apparently healthy adults enrolled in the Korean Sarcopenic Obesity Study (KSOS), an ongoing prospective observational cohort study. Low muscle mass was defined as thigh muscle cross-sectional area divided by weight (percent) of <1 SD below the mean values of young adults in both sexes.
RESULTS: The prevalence rates of low muscle mass in MHNW, MANW, MHO, and MAO subjects were 6.2%, 17.8%, 23.2%, and 33.7%, respectively. In a multiple logistic regression analysis, men with the MANW phenotype showed a remarkably increased risk of low muscle mass (odds ratio = 11.30, 95% confidence interval, 1.73-73.28) compared with those with MHNW. Furthermore, in both men and women, MHO or MAO subjects had higher odds ratios of low muscle mass compared with MHNW subjects.
CONCLUSIONS: The present study suggests that low muscle mass may be associated with different metabolic consequences according to body size phenotype.

Entities:  

Mesh:

Year:  2013        PMID: 23293328     DOI: 10.1210/jc.2012-3292

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  The novel myokine irisin: clinical implications and potential role as a biomarker for sarcopenia in postmenopausal women.

Authors:  Hye-Sun Park; Hyun Chang Kim; Dongdong Zhang; Hyungseon Yeom; Sung-Kil Lim
Journal:  Endocrine       Date:  2018-12-20       Impact factor: 3.633

Review 2.  Body composition assessment for the definition of cardiometabolic risk.

Authors:  M C Amato; V Guarnotta; C Giordano
Journal:  J Endocrinol Invest       Date:  2013-04-23       Impact factor: 4.256

3.  Circulating MicroRNA Are Predictive of Aging and Acute Adaptive Response to Resistance Exercise in Men.

Authors:  Lee M Margolis; Sarah J Lessard; Yassine Ezzyat; Roger A Fielding; Donato A Rivas
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-01       Impact factor: 6.053

Review 4.  Assessment and definition of lean body mass deficiency in the elderly.

Authors:  M J Müller; C Geisler; M Pourhassan; C-C Glüer; A Bosy-Westphal
Journal:  Eur J Clin Nutr       Date:  2014-08-20       Impact factor: 4.016

Review 5.  Fat Matters: Understanding the Role of Adipose Tissue in Health in HIV Infection.

Authors:  Kristine M Erlandson; Jordan E Lake
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

6.  Metabolic health across the BMI spectrum in HIV-infected and HIV-uninfected men.

Authors:  Jordan E Lake; Xiuhong Li; Frank J Palella; Kristine M Erlandson; Dorothy Wiley; Lawrence Kingsley; Lisa P Jacobson; Todd T Brown
Journal:  AIDS       Date:  2018-01-02       Impact factor: 4.632

7.  Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype.

Authors:  Y-C Hwang; T Hayashi; W Y Fujimoto; S E Kahn; D L Leonetti; M J McNeely; E J Boyko
Journal:  Int J Obes (Lond)       Date:  2015-04-29       Impact factor: 5.095

Review 8.  Sarcopenia and sarcopenic obesity.

Authors:  Kyung Mook Choi
Journal:  Endocrinol Metab (Seoul)       Date:  2013-06

9.  Metabolic syndrome, sarcopenia and role of sex and age: cross-sectional analysis of Kashiwa cohort study.

Authors:  Shinya Ishii; Tomoki Tanaka; Masahiro Akishita; Yasuyoshi Ouchi; Tetsuo Tuji; Katsuya Iijima
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

10.  Increasing muscle mass improves vascular function in obese (db/db) mice.

Authors:  Shuiqing Qiu; James D Mintz; Christina D Salet; Weihong Han; Athanassios Giannis; Feng Chen; Yanfang Yu; Yunchao Su; David J Fulton; David W Stepp
Journal:  J Am Heart Assoc       Date:  2014-06-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.